| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.9% | 2.2% |
| Div Cover | 3.4 | 3.5 |
| Op Mrgn | 13.9% | 13.3% |
| ROCE | 17.4% |
| Latest | F'cast | |
|---|---|---|
| P/E | 15.2 | 13.9 |
| PEG | 0.9 | 1.5 |
| Pr/Revenue | 1.6 | 1.4 |
| Pr/Book | 1.6 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 0.3% | 10.6% |
| PBT | 49.7% | 14.8% |
| EPS | 17.1% | 9.5% |
| DPS | 20.0% | 6.3% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Mar-08 | 225.00 | 18.85 | 35.46p | 18.1 | 0.9 | +21% | 10.10p | 1.6% |
| 28-Mar-09 | 274.10 | 16.33 | 37.10p | 8.6 | 1.7 | +5% | 11.00p | 3.4% |
| 29-Mar-09 | 274.10 | 16.33 | 37.10p | 8.6 | n/a | n/a | 11.00p | 3.4% |
| 28-Mar-10 | 286.42 | 24.53 | 45.74p | 13.6 | 0.6 | +23% | 13.20p | 2.1% |
| 03-Apr-11 | 287.31 | 36.73 | 53.54p | 15.4 | 0.9 | +17% | 15.84p | 1.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-12 | 317.69 | 42.18 | 58.65p | 13.9 | 1.5 | +10% | 16.83p | 2.2% |
| 31-Mar-13 | 345.60 | 47.81 | 65.89p | 12.4 | 1.0 | +12% | 19.17p | 2.5% |
| 31-Mar-14 | 369.02 | 53.01 | 72.50p | 11.2 | 1.1 | +10% | 21.38p | 2.7% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Holding(s) in Company | 10-May-2012 | 12:23 | RNS |
| Total Voting Rights | 01-May-2012 | 07:00 | RNS |
| Trading Statement | 12-Apr-2012 | 07:00 | RNS |
| Synergy launches NHS superbug screening | 13-May-2007 | Observer |
| Secret talks row in Isotron takeover | 26-Nov-2006 | Sunday Times |
| Synergy offers £143m for Isotron | 26-Oct-2006 | Times |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 815.00p |
| Change Today | 2.00p |
| % Change | 0.25 % |
| 52 Week High | 981.00p |
| 52 Week Low | 762.50p |
| Volume | 145,947 |
| Shares Issued | 55.42m |
| Market Cap | £451.67m |
| Beta | 0.30 |
| RiskGrade | 87 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 5 |
| Buy | 1 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 16-Nov-11 | 10-Aug-11 |
| Paid | 15-Dec-11 | 06-Sep-11 |
| Amount | 6.82p | 9.84p |
| Time | Volume / Share Price |
| 17:02 | 814 @ 814.73p |
| 16:35 | 25,719 @ 815.00p |
| 16:29 | 7 @ 820.00p |
| 16:29 | 55 @ 820.00p |
| 16:28 | 49 @ 819.50p |
| CEO | Dr Richard M Steeves |
| Finance Director | Gavin Hill |
| Chair | Duncan K Nichol |
You are here: research